Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients

Cancer Nursing

Volumn 35, Issue 4, 2012, Pages

  Bertoglio, Sergio ^a,b   Solari, Nicola ^a   Meszaros, Paolo ^a   Vassallo, Francesca ^a   Bonvento, Maura ^a   Pastorino, Simona ^a   Bruzzi, Paolo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Central venous catheter; Heparin lock; Implanted port; Occlusion; Patency; Saline lock

Indexed keywords

ANTINEOPLASTIC AGENT; HEPARIN; SODIUM CHLORIDE;

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CATHETER CARE; CATHETER INTERMITTENT LOCKING; CATHETER OCCLUSION; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COLON CANCER; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTERNAL JUGULAR VEIN; ITALY; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OVARY CANCER; PARENTERAL NUTRITION; PATIENT SAFETY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBCLAVIAN VEIN; VASCULAR ACCESS; VASCULAR ACCESS DEVICE;

ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; EQUIPMENT DESIGN; FOLLOW-UP STUDIES; HEPARIN; HUMANS; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; SODIUM CHLORIDE; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84862841652     PISSN: 0162220X     EISSN: 15389804     Source Type: Journal    
DOI: 10.1097/NCC.0b013e31823312b1     Document Type: Article

References (31)

1. Tanner WA, Delaney PV, Hennessey TP. The influence of heparin on intravenous infusion: a prospective study. Br J Surg. 1980;67:311-312. (Pubitemid 10038995)
2. Randolph AG, Cook DJ, Gonzalez CA, et al. Benefit of heparin in central venous and pulmonary artery catheters. A meta-analysis of randomized controlled trials. Chest. 1998;113:165-171. (Pubitemid 28044941)
3. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003;348(12):1123-1133. (Pubitemid 36337324)
4. Mitchell MD, Anderson BJ, Williams K, et al. Heparin flushing and other interventions to maintain patency of central venous catheters: a systemic review. J Adv Nurs. 2009;65(10):2007-2021.
5. Bircher AJ, Harr T, Hohenstein L, et al. Hypersensitivity reactions to anticoagulant drugs; diagnosis and management options. Allergy. 2006;6: 1432-1440. (Pubitemid 44665308)
6. Blossom DB, Kallen AJ, Patel PR, et al. Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med. 2008;359:2674-2684.
7. Vorweg M, Monaca E, Dohen M, et al. The "heparin lock": cause for iatrogenic coagulopathy. Eur J Anaesthesiol. 2006;23(1):50-53. (Pubitemid 43038198)
8. Warkentin TE. Heparin-induced thrombocytopenia. Hematol Oncol Clin N Am. 2007;21(4):589-607. (Pubitemid 47102555)
9. Passannante A, Macik BG. Case report: the heparin flush syndrome: a cause of iatrogenic hemorrhage. Am J Med Sci. 1998;296:71-73.
10. Pepper RJ, Gale DP, Wajed J, et al. Inadvertent postdialysis anticoagulation due to heparin line locks. Hemodial Int. 2007;11:430-434. (Pubitemid 47534868)
11. Taylor N, Hutchison E, Milliken W, et al. Comparison of normal versus heparinized saline for flushing infusion devices. J Nurs Qual Assur. 1989; 3(4):49-55.
12. Ashton J, Gibson V, Summers S. Effects of heparin versus saline solution on intermittent infusion device irrigation. Heart Lung. 1990;19:608-612.
13. Goode CJ, Titler M, Rakel B, et al. A meta-analysis of effects of heparin flush and saline flush: quality and cost implications. Nurs Res. 1991; 40(6):324-330.
14. McAllister CG, Lenaghan PA, Tosone NC. Changing from heparin to saline flush solutions: a research utilization model for implementation. J Emerg Nurs. 1993;19(4):306-312.
15. LeDuc K. Efficacy of normal saline solution versus heparin solution for maintaining patency of peripheral intravenous catheters in children. J Emerg Nurs. 1997;23:306-309.
16. Lombardi TP, Gunderson B, Zammett LO, et al. Efficacy of 0.9% sodium chloride injection with or without heparin sodium for marinating patency of intravenous catheters in children. Child Pharm. 1988;7:832-836.
17. Lee OK, Johnston L. A systematic review for effective management of central venous catheters and catheter sites in acute care paediatric patients. Worldviews Evid Based Nurs. 2005;2(1):4-13. (Pubitemid 41702690)
18. Cesaro S, Tridello G, Cavaliere M, et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. J Clin Oncol. 2009;27:2059-2065.
19. Infusion Nursing Society standards of practice. J Infus Nurs. 2011;34(S1): S59-S63.
20. Registred Nurses Association of Ontario Nursing Best Practice. Care and maintenance to reduce vascular access complications; Review (2008). http://www.rnao.org/Storage/3/3980-Care-and-Maintenance-to-Reduce-Vascular- Access-Complications-Supplement-FINAL.pdf. Accessed August 5, 2011.
21. Pratt RJ, Pellowe CM, Wilson JA, et al. epic-2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2007;65(suppl 1):S1-S64.
22. Bishop L, Dougherty L, Bodenham A, et al. Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol. 2007;29:261-278. (Pubitemid 47041489)
23. Camp-Sorell D. State of the science of oncology vascular access devices. Semin Oncol Nurs. 2010;26(2):80-87.
24. Verso M, Agnelli G, Bertoglio S, et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheters: a doubleblind, placebo-controlled, randomized study in cancer patients. J Clin Oncol. 2005;23(18):4057-4062. (Pubitemid 46211310)
25. Peterson FY, Kirchoff KT. Analysis of the research about heparinized versus nonheparinized intravascular lines. Heart Lung. 1991;20:631-640.
26. White C. Venous thromboembolism. Heparins are of porcine origin. BMJ. 2006;332(7537):364.
27. Luciani A, Clement O, Halimi P, et al. Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US. Radiology. 2001;220(3):655-660. (Pubitemid 32799971)
28. Verso M, Agnelli G, Kamphuisen PW, et al. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Int Emerg Med. 2008;3:117-122.
29. Kuter DJ. Thrombotic complications of central venous catheters in cancer patients. Oncologist. 2004;9:207-216. (Pubitemid 38452120)
30. Agnelli G, Verso M. Therapy insight: venous-catheter-related thrombosis in cancer patients. Nat Clin Pract Oncol. 2006;3:214-222.
31. Blom JW, Doggen CJM, Osanto S, et al. Malignancies, prothrombotic mutations and the risk of venous thrombosis. JAMA. 2005;293:715-722. (Pubitemid 40216041)